Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BioConsul Drug Development Corporation was a life sciences consulting firm founded by Dr. Anthony E. Maida, III in 1977. The company provided strategic advisory services to pharmaceutical companies, venture capital firms, hedge funds, and Wall Street investors, focusing on the clinical development of therapeutic products and the evaluation of product or company acquisitions. BioConsul specialized in the oncology and immunotherapy sectors, leveraging Dr. Maida's expertise to guide clients through the complexities of drug discovery, regulatory affairs, and manufacturing. While the company did not maintain its own internal drug pipeline, it played a significant role in the development of numerous external therapeutic programs and the execution of licensing agreements with major pharmaceutical firms.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BioConsul Drug Development.